Clopidogrel and Aspirin Optimal Dose Usage to Reduce Recurrent Events−Seventh Organization to Assess Strategies in Ischemic Syndromes - CURRENT–OASIS 7


CURRENT–OASIS 7 was a 2 × 2 factorial trial that aimed to evaluate the efficacy and safety of a high daily dose of aspirin compared with a low dose of aspirin, and standard-dose clopidogrel compared with double-dose clopidogrel, among patients with ST-elevation myocardial infarction (STEMI) or non–ST-segment elevation acute coronary syndrome (NSTE-ACS).